Format

Send to

Choose Destination
Pancreatology. 2018 Apr;18(3):286-290. doi: 10.1016/j.pan.2018.02.001. Epub 2018 Feb 6.

A multicenter study of total pancreatectomy with islet autotransplantation (TPIAT): POST (Prospective Observational Study of TPIAT).

Author information

1
University of Minnesota Medical School, Minneapolis, MN, United States. Electronic address: bell0130@umn.edu.
2
Cincinnati Children's Hospital, Cincinnati, OH, United States.
3
The Medical University of South Carolina, Charleston, SC, United States.
4
University of Minnesota Medical School, Minneapolis, MN, United States.
5
The Ohio State Wexner University Medical Center, Columbus, OH, United States.
6
Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States.
7
Baylor Simmons Transplant Institute, Dallas, TX, United States.
8
John Hopkins Medical Institutions, Baltimore, MD, United States.
9
University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
10
University of Chicago, Chicago, IL, United States.
11
University of Minnesota School of Public Health, Minneapolis, MN, United States.

Abstract

BACKGROUND/OBJECTIVES:

Total pancreatectomy with islet autotransplantation (TPIAT) is considered for managing chronic pancreatitis in selected patients when medical and endoscopic interventions have not provided adequate relief from debilitating pain. Although more centers are performing TPIAT, we lack large, multi-center studies to guide decisions about selecting candidates for and timing of TPIAT.

METHODS:

Multiple centers across the United States (9 to date) performing TPIAT are prospectively enrolling patients undergoing TPIAT for chronic pancreatitis into the Prospective Observational Study of TPIAT (POST), a NIDDK funded study with a goal of accruing 450 TPIAT recipients. Baseline data include participant phenotype, pancreatitis history, and medical/psychological comorbidities from medical records, participant interview, and participant self-report (Medical Outcomes Survey Short Form-12, EQ-5D, andPROMIS inventories for pain interference, depression, and anxiety). Outcome measures are collected to at least 1 year after TPIAT, including the same participant questionnaires, visual analog pain scale, pain interference scores, opioid requirements, insulin requirements, islet graft function, and hemoglobin A1c. Health resource utilization data are collected for a cost-effectiveness analysis. Biorepository specimens including urine, serum/plasma, genetic material (saliva and blood), and pancreas tissue are collected for future study.

CONCLUSIONS:

This ongoing multicenter research study will enroll and follow TPIAT recipients, aiming to evaluate patient selection and timing for TPIAT to optimize pain relief, quality of life, and diabetes outcomes, and to measure the procedure's cost-effectiveness. A biorepository is also established for future ancillary studies.

KEYWORDS:

Diabetes; Islet; Pain; Pancreatitis; Total pancreatectomy

PMID:
29456124
PMCID:
PMC5879010
[Available on 2019-04-01]
DOI:
10.1016/j.pan.2018.02.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center